CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...
Candidates who wish to contest any answers in the BBOSE answer keys are permitted to submit their objections online.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback